LQDA•benzinga•
Liquidia Litigation Against FDA Over Tyvaso DPI Exclusivity Denied; United Therapeutics' Cross Claim Remains Pending; Exclusivity Expires May 23, 2025
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 28, 2025 by benzinga